Oxford University breakthrough on global COVID-19 vaccine
Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens
Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens
Learn how RNAscope technology was adapted to study plant tissues and gain insights into plant immunity
Dr. Sylvia Boj discusses the advantages of organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response
Studies show that the Abbott i-STAT helps clinicians to make quick, informed decisions
Thermo Fisher Scientific’s Director of Global Research discusses the use of mass spectrometry at the Hong Kong Jockey Club
Find out how the latest advances in multi-omics are being applied to the development of next-generation antifungal therapies
Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus
In this article, Mar Garcia Hernandez, from The Graphene Flagship, explains the potential of experimenting with graphene and related materials
Discover the latest in malaria diagnostics, from currently available techniques to the implementation of effective disease management strategies
Bruker Daltonics and AstraZeneca among those recognized during prestigious ceremony at SLAS2017